| __timestamp | Agios Pharmaceuticals, Inc. | Dr. Reddy's Laboratories Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 100371000 | 56369000000 |
| Thursday, January 1, 2015 | 141827000 | 62786000000 |
| Friday, January 1, 2016 | 220163000 | 62427000000 |
| Sunday, January 1, 2017 | 292681000 | 62453000000 |
| Monday, January 1, 2018 | 1397000 | 65724000000 |
| Tuesday, January 1, 2019 | 1317000 | 70421000000 |
| Wednesday, January 1, 2020 | 2805000 | 80591000000 |
| Friday, January 1, 2021 | 18777000 | 86645000000 |
| Saturday, January 1, 2022 | 1704000 | 100551000000 |
| Sunday, January 1, 2023 | 9504000 | 42907000000 |
| Monday, January 1, 2024 | 4165000 | 115557000000 |
Infusing magic into the data realm
In the ever-evolving pharmaceutical industry, understanding cost dynamics is crucial. Dr. Reddy's Laboratories Limited, a major player from India, has consistently demonstrated robust cost management. From 2014 to 2023, their cost of revenue has shown a steady upward trend, peaking at approximately 115% of their 2014 figures by 2024. In contrast, Agios Pharmaceuticals, Inc., a U.S.-based biotech firm, presents a more volatile picture. Their cost of revenue fluctuated significantly, with a notable spike in 2017, reaching nearly 300% of their 2014 costs, before stabilizing in subsequent years. This disparity highlights the strategic differences in operational management between established pharmaceutical giants and emerging biotech firms. Notably, the data for 2024 is incomplete for Agios, indicating potential shifts in their financial strategy. As the industry continues to innovate, these trends offer valuable insights into the financial health and strategic priorities of these companies.
Cost of Revenue Trends: Pfizer Inc. vs Agios Pharmaceuticals, Inc.
Cost of Revenue Comparison: Vertex Pharmaceuticals Incorporated vs Dr. Reddy's Laboratories Limited
Cost of Revenue: Key Insights for Zoetis Inc. and Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Teva Pharmaceutical Industries Limited vs Agios Pharmaceuticals, Inc.
Analyzing Cost of Revenue: Dr. Reddy's Laboratories Limited and Ionis Pharmaceuticals, Inc.
Cost Insights: Breaking Down Dr. Reddy's Laboratories Limited and Xenon Pharmaceuticals Inc.'s Expenses
Cost of Revenue Comparison: Dr. Reddy's Laboratories Limited vs Iovance Biotherapeutics, Inc.
Analyzing Cost of Revenue: BioMarin Pharmaceutical Inc. and Agios Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Corcept Therapeutics Incorporated vs Agios Pharmaceuticals, Inc.
Cost of Revenue Trends: Cytokinetics, Incorporated vs Agios Pharmaceuticals, Inc.
Comparing Cost of Revenue Efficiency: Agios Pharmaceuticals, Inc. vs Galapagos NV
Cost of Revenue: Key Insights for Agios Pharmaceuticals, Inc. and Celldex Therapeutics, Inc.